Table 1 Patients and treatment characteristics
Patient number | 1 | 2 | 3/3a | 4 | 5 |
|---|---|---|---|---|---|
Sex (male/female) | m | m | f | f | m |
Age (years) | 56 | 36 | 49 | 61 | 67 |
Primary disease | Autoimmune hepatitis | Cystic fibrosis | Autoimmune hepatitis | Granulomatous liver disease | M. Werlhof with liver cirrhosis |
Single/total dose | 0.5/3.0 Gy | 0.5/3.0 Gy | 0.5/3.0 Gy Second course (3a): 0.5/3.0 Gy | 0.5/3.0 Gy | 0.5/3.0 Gy |
Follow-up (months) | 21 | 35 | 24 (36) and (3a) 12 | 7 | 2 |